PDL-1

Clinical trials for PDL-1 explained in plain language.

Never miss a new study

Get alerted when new PDL-1 trials appear

Sign up with your email to follow new studies for PDL-1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New Triple-Threat therapy tested for aggressive stomach cancers

Disease control Recruiting now

This study is testing a new three-drug combination for people with advanced stomach or esophageal cancer that has spread. It's for patients who have not yet received treatment for their advanced cancer and whose tumors test positive for two specific markers (HER2 and PD-L1). The …

Matched conditions: PDL-1

Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

PDL-1

Get alerted when new PDL-1 trials appear

New Triple-Threat therapy tested for aggressive stomach cancers